ASCO 2025 | The potential of VTP in low-grade upper tract urothelial carcinoma

Vitaly Margulis • 31 May 2025

ASCO 2025

Vitaly Margulis, MD UT Southwestern Medical Center, Dallas, TX, briefly shares his insights on using novel organ-sparing approaches in the treatment of upper tract urothelial carcinoma (UTUC). He notes that while organ-sparing approaches, such as vascular-targeted photodynamic therapy (VTP), are preferred and utilized currently for low-grade tumors, they have yet to be implemented for UTUC. This interview took place at the 2025 American Society of Clinical Oncology (ASCO) meeting in Chicago, IL.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.